ArticleToxicological sciences : an official journal of the Society of Toxicology2026
A cell-based Sonic Hedgehog signaling transduction system to identify additive and synergistic chemical interactions.
Article in Toxicological sciences : an official journal of the Society of Toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Hedgehog pathway disruption alters urothelial differentiation and continence mechanisms in the female mouse lower urinary tract.American journal of physiology. Renal physiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Chemical co-exposures are important contributors to adverse biological responses yet remain poorly understood, especially in the context of prenatal development. Sonic Hedgehog (Shh) signaling is an essential developmental pathway that is sensitive to small-molecule disruption and directly linked to common and etiologically complex human birth defects. Numerous mechanistically diverse small-molecule Shh pathway antagonists have been identified, but their interactions in pathway disruption have received minimal attention. We established a tractable co-culture model in which autonomous SHH ligand production initiates this complex inter- and intracellular signal transduction cascade and culminates in activation of a GLI-responsive luminescent reporter. Compounds reported to target SHH ligand processing (RU-SKI 43, AY 9944, U18666A), SMO-mediated signal transduction (cyclopamine, vismodegib, piperonyl butoxide, cannabidiol), and GLI transcription factors (GANT 61, arsenic trioxide) reduced Shh pathway-driven reporter activity with AC50 values in the low micromolar range or below. We then evaluated chemical interactions among Shh pathway inhibitors using isobolographic analysis. Co-exposure assays revealed additive interactions from combined SMO and GLI inhibition, whereas disruption of SMO and cholesterol dynamics synergistically decreased Shh pathway activity. Unexpectedly, piperonyl butoxide synergized with other SMO inhibitors, and further characterization of piperonyl butoxide's impacts on Shh signaling supported an additional mechanism of inhibition independent of SMO. In zebrafish embryos, combined exposure to piperonyl butoxide and cyclopamine also produced a synergistic increase in craniofacial dysmorphogenesis. These findings demonstrate the importance of tractable models that recapitulate complex signal transduction pathways to empirically test for additive and synergistic chemical interactions in risk assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.